CAXTON CORP - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 60 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$16,370,000
-31.8%
8,024,542
-0.7%
13.27%
-19.4%
Q2 2021$24,008,000
+7.6%
8,083,4420.0%16.45%
+13.5%
Q1 2021$22,310,000
+13.5%
8,083,442
-0.1%
14.49%
+18.3%
Q4 2020$19,657,000
+15.7%
8,089,4420.0%12.25%
-23.5%
Q3 2020$16,988,000
-32.0%
8,089,442
+22.3%
16.02%
-39.3%
Q2 2020$24,994,000
+100.0%
6,612,0650.0%26.38%
+93.1%
Q1 2020$12,497,000
-9.6%
6,612,0650.0%13.66%
+2.5%
Q4 2019$13,819,000
-12.6%
6,612,0650.0%13.33%
-25.2%
Q3 2019$15,803,000
-23.6%
6,612,0650.0%17.82%
-24.2%
Q2 2019$20,696,000
-37.1%
6,612,0650.0%23.51%
-23.1%
Q1 2019$32,928,000
+11.3%
6,612,065
+0.1%
30.56%
-14.9%
Q4 2018$29,586,000
-3.1%
6,604,065
+4.9%
35.89%
+27.2%
Q3 2018$30,530,000
-5.7%
6,294,789
+16.6%
28.22%
+146.6%
Q2 2018$32,388,000
-31.5%
5,398,034
+0.4%
11.44%
-77.7%
Q1 2018$47,309,000
+18.3%
5,376,039
-2.5%
51.34%
+5.6%
Q4 2017$39,984,000
+5.1%
5,514,9940.0%48.61%
+25.5%
Q3 2017$38,053,000
-1.4%
5,514,994
+2.2%
38.73%
-35.6%
Q2 2017$38,574,000
+50.5%
5,394,9940.0%60.18%
-17.7%
Q1 2017$25,626,000
+97.9%
5,394,9940.0%73.15%
+65.6%
Q4 2016$12,948,000
+6937.0%
5,394,994
+15207.1%
44.18%
+5261.0%
Q3 2016$184,000
+28.7%
35,245
-2.0%
0.82%
+411.8%
Q2 2016$143,00035,9770.16%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$12,497,00013.66%
Ikarian Capital, LLC 3,392,787$6,412,0000.48%
NEA Management Company, LLC 4,141,308$7,827,0000.41%
Alambic Investment Management, L.P. 61,764$117,0000.28%
KNOTT DAVID M 181,800$344,0000.22%
683 Capital Management, LLC 917,942$1,736,0000.10%
Hudson Bay Capital Management LP 1,409,419$2,664,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 388,309$734,0000.06%
&PARTNERS 15,000$28,0000.04%
Diversified Trust Co 198,534$375,0000.02%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders